ZIDRION 80 CR Capsules – Trimetazidine Hydrochloride Controlled Release 80 mg
Description
Trimetazidine Hydrochloride Controlled Release Capsules 80 mg contains trimetazidine is a sustained-release formulation designed for the long-term management of stable angina pectoris. Trimetazidine acts as a metabolic modulator that improves cardiac efficiency by optimizing energy utilization in myocardial cells, even under low oxygen conditions. The controlled-release design ensures a steady and prolonged release of the drug, maintaining consistent plasma concentrations and providing lasting symptom relief throughout the day.
Key Points
✅Enhances Myocardial Energy Efficiency: Improves cardiac metabolism without altering heart rate or blood pressure.
✅Minimizes Angina Episodes: Supports energy balance in ischemic heart tissue, reducing frequency and intensity of chest pain.
✅ Prolonged Therapeutic Effect: Once-daily controlled-release formulation delivers 24-hour symptom control and better treatment adherence.
Targeted Specialties:
✅Cardiology
✅General Medicine
✅Geriatrics
✅Critical Care Medicine
Disclaimer: To be administered only under the supervision of a qualified healthcare professional. Intended for use by registered medical practitioners. Not for public promotion







